Last reviewed · How we verify
Plasmodium Ovale Malaria Prevention
Approved treatments
- Hydroxychloroquine Sulfate · Sanofi
Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and modulating the immune system to treat autoimmune diseases. - Aralen · Sanofi
Aralen works by accumulating in the acidic compartments of the malaria parasite, disrupting its metabolism and ultimately leading to its death. - Hydroxychloroquine Sulfate · Advanz
Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and reducing inflammation in the body. - Hydroxychloroquin · Children's Hospital of Fudan University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Plasmodium Ovale Malaria Prevention patent landscape — cliff calendar, originator estates, attackable patents
- Plasmodium Ovale Malaria Prevention treatment landscape brief
- Plasmodium Ovale Malaria Prevention treatment updates RSS
Frequently asked questions about Plasmodium Ovale Malaria Prevention
What drugs treat Plasmodium Ovale Malaria Prevention?
Tracked treatments include Hydroxychloroquine Sulfate, Aralen, Hydroxychloroquin.
What is the treatment for Plasmodium Ovale Malaria Prevention?
Standard treatment for Plasmodium Ovale Malaria Prevention includes Hydroxychloroquine Sulfate, Aralen, Hydroxychloroquin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Plasmodium Ovale Malaria Prevention patent cliff · Plasmodium Ovale Malaria Prevention CI report
- Treatment: Hydroxychloroquine Sulfate · Sanofi
- Treatment: Aralen · Sanofi
- Treatment: Hydroxychloroquine Sulfate · Advanz
- Treatment: Hydroxychloroquin · Children's Hospital of Fudan University
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing